More on BCRX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.50 |
|
|||
| Open | $8.47 | ||||
| 52 Wk High | $10.98 | ||||
| 52 Wk Low | $1.63 | ||||
| Day High | $8.74 | ||||
| Day Low | $8.45 | ||||
| P/E | N/A | ||||
| EPS | $-0.68 | ||||
| Volume | 2,394,496 | ||||
- Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 11
- BioCryst presents HAE treatment data at European allergy meeting
- BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Milne Jill C.
- Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Stonehouse Jon P
- Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: McKee Amy E
- Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: MILANO VINCENT
- Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Frank Steven
- BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
Entities mentioned with BCRX
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
